Table 4. . Patients’ characteristics in a validation set.
| Characteristic | Short OS (n = 11) | Long OS (n = 12) |
Hazard ratio 95% CI |
p-value† | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Age (years): | |||||
| – Mean (range) |
48.9 (28–63) |
50.8 (30–71) |
0.14 |
5.48 |
0.90 |
| Gender: | |||||
| – Male (%) |
7 (58) |
7 (63) |
0.21 |
1.88 |
0.40 |
| KPS: | |||||
| – Mean (range) |
78 (50–100) |
84 (50–100) |
0.08 |
2.21 |
0.29 |
| Surgical treatment (%) |
10 (91) |
12 (100) |
0.06 |
19.9 |
0.86 |
| Chemotherapy, No. (%) |
9 (82) |
10 (83) |
0.11 |
2.12 |
0.28 |
| RT before vaccination (Gy): | |||||
| – Average (SD) | 57 (9.0) | 59 (2.9) | 0.005 | 2.54 | 0.13 |
†Cox proportional hazard regression with the OS from vaccination started as the time variable was used.
KPS: Karnovski performance status; OS: Overall survival; RT: Radio therapy (total absorbed dose); SD: Standard deviation.